Alectinib; ATC Code: L01ED03

This tender concerns the supply of Alectinib, identified by the Anatomical Therapeutic Chemical (ATC) classification code L01ED03. Alectinib is a targeted therapy drug used primarily in the treatment of certain types of cancer, specifically anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). The ATC code provides a standardized classification for pharmaceutical substances. This procurement is likely for a healthcare provider, hospital, or pharmaceutical distributor seeking to acquire this specific medication. The tender will specify the required pharmaceutical grade, dosage forms (e.g., capsules), packaging, quantities, and delivery conditions. The objective is to ensure the availability of this important oncology drug for patient treatment. Bidders must demonstrate their ability to supply Alectinib in compliance with all relevant pharmaceutical regulations and quality standards.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Germany, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before March 5, 2028.

Published through TED - Tenders Electronic Daily (EU), a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.